1832 Asset Management’s Oncolytics Biotech ONCY Stock Holding History

1832 Asset Management’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5	Closed	-$5	–	836
2024 Q2	$5	Hold	5	–	–	﹤0.01%	884
2024 Q1	$5	Hold	5	–	–	﹤0.01%	881
2023 Q4	$7	Hold	5	–	–	﹤0.01%	827
2023 Q3	$10	Hold	5	–	–	﹤0.01%	848
2023 Q2	$13	Hold	5	–	–	﹤0.01%	845
2023 Q1	$6	Hold	5	–	–	﹤0.01%	882
2022 Q4	$8	Hold	5	–	–	﹤0.01%	884
2022 Q3	$0	Hold	5	–	–	﹤0.01%	912
2022 Q2	$0	Hold	5	–	–	﹤0.01%	931
2022 Q1	$0	Hold	5	–	–	﹤0.01%	967
2021 Q4	$0	Hold	5	–	–	﹤0.01%	827
2021 Q3	$0	Hold	5	–	–	﹤0.01%	875
2021 Q2	$0	Hold	5	–	–	﹤0.01%	763
2021 Q1	$0	Hold	5	–	–	﹤0.01%	754
2020 Q4	$0	Sell	5 -421	-99%	-$1.01K	﹤0.01%	734
2020 Q3	$1K	Hold	426	–	–	﹤0.01%	677
2020 Q2	$1K	Hold	426	–	–	﹤0.01%	639
2020 Q1	$1K	Buy	426 +421	+8,420%	+$1.05K	﹤0.01%	658
2019 Q4	$0	Hold	5	–	–	﹤0.01%	725
2019 Q3	$0	Hold	5	–	–	﹤0.01%	735
2019 Q2	$0	Hold	5	–	–	﹤0.01%	740
2019 Q1	$0	Hold	5	–	–	﹤0.01%	687
2018 Q4	$0	Hold	5	–	–	﹤0.01%	701
2018 Q3	$0	Hold	5	–	–	﹤0.01%	701
2018 Q2	$0	Buy	+5	New	+$31	﹤0.01%	713

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

1832 Asset Management's ONCY Position: Q3 2024 in Review

1832 Asset Management sold out of Oncolytics Biotech (ONCY) in Q3 2024, closing a stake of 5 shares — an estimated $5 sold.

1832 Asset Management first reported a position in ONCY in Q2 2018 and held it in 25 quarters. The position peaked at $1K in Q3 2020. 42 funds tracked by Wall St. Rank hold ONCY as of Q3 2024.

1832 Asset Management reported no remaining Oncolytics Biotech position as of Q3 2024 after selling out during the quarter.
1832 Asset Management sold 5 Oncolytics Biotech shares in Q3 2024, an estimated $5.
1832 Asset Management first reported a position in Oncolytics Biotech in Q2 2018 and held it in 25 quarters.
1832 Asset Management's Oncolytics Biotech position peaked at $1K in Q3 2020.
42 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2024.

Based on 1832 Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.